Bridges to transplantation

Anesthesiology Clinics of North America

Volumn 22, Issue 4, 2004, Pages 863-869

  Punch, Jeffrey D ^a  

^a UNIVERSITY OF MICHIGAN MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALBUMIN; ANTIBIOTIC AGENT; BENZODIAZEPINE RECEPTOR BLOCKING AGENT; DEXAMETHASONE; FLUMAZENIL; MANNITOL; NEOMYCIN; PENTOBARBITAL;

ARTIFICIAL VENTILATION; BRAIN EDEMA; BRAIN HERNIA; BRAIN ISCHEMIA; CHRONIC LIVER DISEASE; CLINICAL TRIAL; HEAD INJURY; HEMODIALYSIS; HEMOFILTRATION; HEPATIC ENCEPHALOPATHY; HUMAN; LIVER CIRRHOSIS; LIVER FAILURE; LIVER PERFUSION; LIVER TRANSPLANTATION; NONHUMAN; REVIEW; SOMNOLENCE;

HUMANS; LIVER FAILURE, ACUTE; LIVER TRANSPLANTATION; LIVER, ARTIFICIAL; SORPTION DETOXIFICATION;

EID: 8444234270     PISSN: 08898537     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.atc.2004.05.008     Document Type: Review

References (35)

1. Schalm S.W., de Knegt R.J. Acute liver failure: definitions and pathological variants. Williams R., Hughes R.D. Acute liver failure: improved understanding and better therapy. 1991;11-13 Miter Press, London
2. Lee W.M. Acute liver failure. N Engl J Med. 329(25):1993;1862-1872
3. Ostapowicz G., Fontana R.J., Schiodt F.V., Larson A., Davern T.J., Han S.H., et al. for the US Acute Liver Failure Study Group Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States. Ann Intern Med. 137(12):2002;947-954
4. Wootton F.T., Lee W.M. Acetaminophen hepatotoxicity in the alcoholic. South Med J. 83:1990;1047-1049
5. Anonymous The brain in fulminant hepatic failure (editorial). Lancet. 338:1991;156-157
6. Basile A.S., Hughes R.D., Harrison P.M., Murata Y., Pannel L., Jones E.A., et al. Elevated brain concentrations of 1,4-benzodiazepines in fulminant hepatic failure. N Engl J Med. 325:1991;473-478
7. Butterworth R.F. Role of circulating neurotoxins in the pathogenesis of hepatic encephalopathy: potential for improvement following their removal by liver assist devices. Liver Int. 23(Suppl 3):2003;5-9
8. Goulenok C., Bernard B., Cadranel J.F., Thabut D., Di Martino V., Opolon P., et al. Flumazenil vs. placebo in hepatic encephalopathy in patients with cirrhosis: a meta-analysis. Aliment Pharmacol Ther. 16(3):2002;361-372
9. Blei A.T., Cordoba J. Practice parameters committee of the American College of Gastroenterology. Hepatic encephalopathy. Am J Gastroenterol. 96(7):2001;1968-1976
10. Keays R.T., Alexander G.J., Williams R. The safety and value of extradural intracranial pressure monitors in fulminant hepatic failure. J Hepatol. 18(2):1993;205-209
11. Davenport A., Will E.J., Davison A.M. Effect of posture on intracranial pressure and cerebral perfusion pressure in patients with fulminant hepatic and renal failure after acetaminophen self-poisoning. Crit Care Med. 18:1990;286-289
12. Canalese J., Gimson A.E.S., Davis C., Mellon P.J., Davis M., Williams R. Controlled trial of dexamethasone and mannitol for the cerebral edema of fulminant hepatic failure. Gut. 23:1982;625-629
13. 2003 OPTN/SRTR Annual Report: Transplant Data 1993-2002. HHS/HRSA/SPB/DOT; UNOS; URREA. (Table 9.2). Available at: www.ustransplant.org
14. O'Grady J.G., Gimson A.E., O'Brien C.J., Pucknell A., Hughes R.D., Williams R. Controlled trials of charcoal hemoperfusion and prognostic factors in fulminant hepatic failure. Gastroenterology. 94(5 Pt 1):1998;1186-1192
15. Ash S.R., Blake D.E., Carr D.J., Carter C., Howard T., Makowka L. Clinical effects of a sorbent suspension dialysis system in treatment of hepatic coma (the BioLogic-DT). Int J Artif Organs. 15(3):1992;151-161
16. Ash S.R., Steczko J., Knab W.R., Blake D.E., Carr D.J., Harker K.D., et al. Push-pull sorbent based pharesis and hemodiabsorption in the treatment of hepatic failure: preliminary results of a clinical trial with the Biologic-DTPF system. Ther Apher. 4(3):2000;218-228
17. Steczko J., Ash S.R., Blake D.E., Carr D.J., Bosley R.H. Cytokines and endotoxin removal by sorbents and its application in push-pull sorbent-based pheresis: the BioLogic-DTPF System. Int J Artif Organs. 23(4):1999;310-318
18. Hughes R.D., Pucknell A., Routley D., Langley P.G., Wendon J.A., Williams R. Evaluation of the BioLogic-DT sorbent-suspension dialyser in patients with fulminant hepatic failure. Int J Artif Organs. 17(12):1994;657-662
19. Wilkinson A.H., Ash S.R., Nissenson A.R. Hemodiabsorption in treatment of hepatic failure. J Transpl Coord. 8(1):1998;43-50
20. Stange J., Ramlow W., Mitzner S., Schmidt R., Klinkmann H. Dialysis against a recycled albumin solution enables the removal of albumin-bound toxins. J Int Artif Organs. 17(9):1993;809-813
21. Awad S., Rich P.B., Kolla S., Younger J.G., Reichert C.A., Downing V.P., et al. Characteristics of an albumin dialysate hemodiafiltration system for the clearance of unconjugated bilirubin. ASAIO J. 43:1997;M745-M749
22. Stange J., Mitzner S.R., Risler T., Erley C.M., Lauchart W., Goehl H., et al. Molecular adsorbent recycling system (MARS): clinical results of a new membrane-based blood purification system for bioartificial liver support. Int J Artif Organs. 23(4):1999;319-330
23. Stange J., Hassanein T.I., Mehta R., Mitzner S.R., Bartlett R.H. The molecular adsorbents recycling system as a liver support system based on albumin dialysis: a summary of preclinical investigations, prospective, randomized, controlled clinical trial, and clinical experience from 19 centers. Artificial Organs. 26(2):2002;103-110
24. Awad S.S., Swaniker F., Magee J., Punch J., Bartlett R.H. Results of a phase I trial evaluating a liver support device utilizing albumin dialysis. Surgery. 130(2):2001;354-362
25. Stange J., Mitzner S.R., Klammt S., Freytag J., Peszynski P., Loock J., et al. Liver support by extracorporeal blood purification: a clinical observation. Liver Transpl. 6(5):2000;603-613
26. Horslen S.P., Hammel J.M., Fristoe L.W., Kangas J.A., Collier D.S., Sudan D.L., et al. Extracorporeal liver perfusion using human and pig livers for acute liver failure. Transplantation. 70(10):2000;1472-1478
27. Pitkin Z., Mullon C. Evidence of absence of porcine endogenous retrovirus (PERV) infection in patients treated with a bioartificial liver support system. Int J Artif Organs. 23(9):1999;829-833
28. Irgang M., Sauer I.M., Karlas A., Zeilinger K., Gerlach J.C., Kurth R., et al. Porcine endogenous retroviruses: no infection in patients treated with a bioreactor based on porcine liver cells. J Clin Virol. 28(2):2003;141-154
29. Rozga J., Holzman M.D., Ro M.S., Griffin D.W., Neuzil D.F., Giorgio T., et al. Development of a hybrid bioartificial liver. Ann Surg. 217(5):1993;502-509. discussion: 509-11
30. Wood R.P., Katz S.M., Ozaki C.F., Monsour H.P., Gislason G.T., Kelly J.H., et al. Extracorporeal liver assist device (ELAD): a preliminary report. Transplantation Proc. 25(Suppl 3):1993;S53-S54
31. Gerlach J.C. Development of a hybrid liver support system: a review. Int J Artif Organs. 19(11):1996;645-654
32. Bertani H., Gelmini R., Del Buono M.G., De Maria N., Girardis M., Solfrini V., et al. Literature overview on artificial liver support in fulminant hepatic failure: a methodological approach. Int J Artif Organs. 25(10):2002;903-910
33. Chen S.C., Hewitt W.R., Watanabe F.D., Eguchi S., Kahaku E., Middleton Y., et al. Clinical experience with a porcine hepatocyte-based liver support system. Int J Artif Organs. 19(11):1996;664-669
34. Ellis A.J., Hughes R.D., Wendon J.A., Dunne J., Langley P.G., Kelly J.H., et al. Pilot-controlled trial of the extracorporeal liver assist device in acute liver failure. Hepatology. 24(6):1996;1446-1451
35. Sauer I.M., Zeilinger K., Obermayer N., Pless G., Grunwald A., Pascher A., et al. Primary human liver cells as source for modular extracorporeal liver support-a preliminary report. Int J Artif Organs. 25(10):2002;1001-1005